XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Changes in Common Stock Options

The following summarizes the changes in common stock options for the three months ended March 31, 2025:

 




 

 

Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining Contractual Term (Years)

 

 

Aggregate Intrinsic Value (In thousands)

 

Outstanding as of December 31, 2024

 

 

2,231,600

 

 

$

1.77

 

 

 

6.0

 

 

$

1,455

 

Granted

 

 

70,000

 

 

$

2.11

 

 

 

 

 

 

 

Exercised

 

 

 

 

$

 

 

 

 

 

 

 

Forfeited

 

 

(60,000

)

 

$

3.05

 

 

 

 

 

 

 

Outstanding as of March 31, 2025

 

 

2,241,600

 

 

$

1.75

 

 

 

5.8

 

 

$

1,457

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options exercisable as of March 31, 2025

 

 

1,626,725

 

 

$

1.52

 

 

 

4.9

 

 

$

1,339

 

DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAward

The following summarizes the restricted stock awards and related stock-based compensation expense (in thousands, except share count and award fair value):

 

 

 

 

 

 

 

 

Compensation Expense for the three months ended March 31,

 

Unrecognized Compensation Expense as of,

 

 

 

Grant Date

Vesting Date

Restricted Stock Granted

 

Per Share Grant Date Fair Value

 

2024

 

2025

 

March 31, 2025

 

Employees

 

March 1, 2023

March 1, 2024

 

97,290

 

$

2.53

 

 

 

 

 

 

 

Non-executive directors

 

March 31, 2023

March 31, 2024

 

90,000

 

$

2.87

 

 

39

 

 

 

 

 

Employees

 

March 7, 2024

March 7, 2025

 

128,044

 

$

2.93

 

 

29

 

 

67

 

 

 

Non-executive directors

 

March 7, 2024

March 7, 2025

 

75,000

 

$

2.93

 

 

17

 

 

40

 

 

 

Employees

 

January 1, 2025

December 31, 2028 [1]

 

125,000

 

$

1.85

 

 

 

 

14

 

 

217

 

Employees

 

March 6, 2025

March 6, 2026

 

128,044

 

$

2.11

 

 

 

 

10

 

 

133

 

Non-executive directors

 

March 6, 2025

March 6, 2026 [2]

 

100,000

 

$

2.11

 

 

 

 

15

 

 

197

 

Total

 

 

 

 

 

 

 

$

85

 

$

146

 

$

547

 

[1] These restricted stock awards vest 25% annually over four years, until fully vested on December 31, 2028.

[2] These restricted stock awards vest 25% quarterly over one year, until fully vested on March 6, 2026.